Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
Alta Global Group | MMA | 5. nov 2024 | 2.48 | +4.64 |
Altair Engineering A | ALTR | 5. nov 2024 | 104.52 | +0.51 |
Altamira Therapeutics | CYTO | 5. nov 2024 | 0.52 | +0.39 |
AltEnergy Acquisition A | AEAE | 5. nov 2024 | 11.22 | 0.00 |
AltEnergy Acquisition Unit | AEAEU | 5. nov 2024 | 11.30 | 0.00 |
Alterity Therapeutics ADR | ATHE | 5. nov 2024 | 1.18 | +3.89 |
Alternus Clean Energy A | ALCE | 5. nov 2024 | 2.38 | -0.42 |
Alti Global A | ALTI | 5. nov 2024 | 4.67 | +8.10 |
Altice USA A | ATUS | 5. nov 2024 | 2.53 | -2.32 |
Altimmune | ALT | 5. nov 2024 | 7.03 | +3.53 |
Altisource Portfolio Solutions | ASPS | 5. nov 2024 | 1.14 | -4.20 |
Alto Ingredients | ALTO | 5. nov 2024 | 1.93 | -0.52 |
Alto Neuroscience | ANRO | 5. nov 2024 | 3.75 | +1.08 |
Altria Group | MO | 5. nov 2024 | 54.19 | +0.58 |
Altus Power A | AMPS | 5. nov 2024 | 3.65 | +3.11 |
Alumis | ALMS | 5. nov 2024 | 11.95 | +4.64 |
Alvotech | ALVO | 5. nov 2024 | 12.90 | -0.15 |
ALX Oncology | ALXO | 5. nov 2024 | 1.52 | +2.01 |
Alzamend Neuro | ALZN | 5. nov 2024 | 1.64 | -0.61 |
Amalgamated Financial | AMAL | 5. nov 2024 | 33.35 | +1.15 |
Amarin ADR | AMRN | 5. nov 2024 | 0.62 | +3.06 |
Amazon.com | AMZN | 5. nov 2024 | 199.50 | +1.90 |
Ambac Financial Group | AMBC | 5. nov 2024 | 11.25 | +0.36 |
Ambarella | AMBA | 5. nov 2024 | 56.70 | -0.67 |
Ambev ADR | ABEV | 5. nov 2024 | 2.22 | +0.45 |
Ambipar Emergency Response | AMBI | 5. nov 2024 | 6.68 | -1.91 |
Ambow Education A ADR | AMBO | 5. nov 2024 | 1.57 | 0.00 |
AMC Entertainment A | AMC | 5. nov 2024 | 4.39 | +0.92 |
AMC Networks A | AMCX | 5. nov 2024 | 8.52 | +3.78 |
AMCON Distributing | DIT | 5. nov 2024 | 132.85 | 0.00 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.